Payers and health technology assessment (HTA) bodies across the Middle East increasingly base access and reimbursement decisions on robust health-economic evidence. The HEOR Manager, Middle East adapts global economic models and value dossiers to local requirements, develops budget-impact analyses, strengthens the real-world-evidence base, and translates evidence into clear payer value narratives that support patient access to innovative medicines.
Based in Cairo and supporting markets across the region, the role works closely with market access, Medical, Commercial and global HEOR colleagues. Priorities include new product launches and reimbursement submissions across a portfolio spanning rare disease, oncology and vaccines.
CORE ACCOUNTABILITIES
1. MODEL AND DOSSIER ADAPTATION
- Adapt global cost-effectiveness and budget-impact models and value dossiers to the requirements of national payers, HTA bodies, insurers and tender authorities across the region; document assumptions and data sources transparently.
- Quality-review dossiers and value materials before external use, in line with company and global HEOR standards.
2. REAL-WORLD EVIDENCE AND LOCAL DATA
- Identify and close local evidence gaps with Medical and global HEOR: burden-of-disease, epidemiology, treatment-pattern and outcomes data; support registries where payers require them.
- Maintain a regional evidence inventory by product and market.
3. PAYER VALUE NARRATIVES
- Translate models and evidence into value stories, objection handlers and budget-impact summaries for market access colleagues across the region.
- Support managed-entry and outcome-based agreement design with the evidence and outcome measures they require.
4. LAUNCH READINESS AND PRIORITIZATION
- Deliver evidence packages for new product launches and maintain a prioritized HEOR work plan aligned with regional access priorities.
5. CAPABILITY BUILDING AND IMPACT
- Coach access colleagues on using health-economic evidence with payers; track evidence delivery against submission timelines and payer feedback.
- Success is measured by on-time delivery of evidence for priority submissions and launches, the quality of payer-facing dossiers, and payer feedback on the evidence provided.
DECISION RIGHTS
- Determines methods and adaptation approach within global HEOR standards; recommends evidence-generation investments.
- Confirms the technical accuracy of models and dossiers before release.
- Prioritizes the evidence work plan with the line manager and regional access leads.
CAPABILITIES & QUALIFICATIONS
- Bachelor's degree in Health Economics, Epidemiology, Public Health, Pharmacy or a related quantitative field.
- Minimum 3 years in HEOR, market access or outcomes research in pharma, consulting or academia.
- Demonstrated health-economics modelling experience (cost-effectiveness or budget-impact) and dossier writing.
- Proficiency in Excel and at least one statistical or modelling tool (R, Python, TreeAge or equivalent).
- Fluent business English.
PREFERRED
- MSc or PhD in Health Economics, Epidemiology, Public Health or a related quantitative field.
- Experience in the pharmaceutical industry.
- Experience adapting global models and dossiers for Middle East payers.
- Real-world-evidence or registry experience.
- Experience presenting evidence to payers or HTA bodies.
- Arabic language.
CRITICAL LEADERSHIP BEHAVIORS
Strategic Influence
Challenges the status quo and influences stakeholders without direct authority.
Cross-Functional Collaboration
Works seamlessly across Market Access, Commercial, Medical and therapy-area teams.
Accountability & Delivery
Owns results and delivers on time against clear milestones.
Agility & Analytical Thinking
Manages complexity, decides on evidence and adapts quickly.
KEY ORGANIZATIONAL RELATIONSHIPS
- Internal: line manager and Pricing & HTA colleagues; market access teams across the region
- Medical, Commercial and therapy-area teams; global and regional HEOR teams
- External: HTA bodies, payers and reimbursement authorities, in partnership with market access
OPERATING MODEL
Individual contributor based in Cairo, Egypt, supporting markets across the Middle East. No direct reports.
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers .
Market Access
Skills Required
- Bachelor's degree in Health Economics, Epidemiology, Public Health, Pharmacy, or a related quantitative field
- Minimum 3 years of experience in HEOR, market access, or outcomes research in pharma, consulting, or academia
- Health-economics modeling experience, including cost-effectiveness or budget-impact modeling
- Experience writing health-economic dossiers
- Proficiency in Excel
- Proficiency in at least one statistical or modeling tool such as R, Python, or TreeAge
- Fluent business English
- MSc or PhD in Health Economics, Epidemiology, Public Health, or a related quantitative field
- Pharmaceutical industry experience
- Experience adapting global models and dossiers for Middle East payers
- Real-world-evidence or registry experience
- Experience presenting evidence to payers or HTA bodies
- Arabic language skills
Pfizer Compensation & Benefits Highlights
How does Pfizer ensure its pay and bonus plans are competitive?
Pfizer supports competitive pay through a pay-for-performance approach, total rewards programs, financial benefits and governance practices tied to compensation oversight. Employees and external reviewers point to compensation, benefits, bonuses, time off and stock-related rewards as part of Pfizer’s workplace value proposition.
- Pay-for-performance compensation: Pfizer structures its compensation policies and practices so colleagues are rewarded based on the contributions they make to the business. This approach connects pay to performance, impact and business outcomes, while supporting Pfizer’s broader goal of attracting and retaining talent across research, manufacturing, commercial, digital and corporate functions.
- Total rewards beyond base pay: Pfizer’s total rewards approach includes pay, health and wellness programs, financial benefits and career development resources. The company references country-specific health and disability insurance, preventative health resources, retirement funds, company contributions, life insurance and financial planning education. An R&D data privacy steward said, “Pfizer aces at taking care of its people,” pointing to educational assistance and health care subsidy in retirement. On external review sites, employees also describe Pfizer as offering a “great compensation package,” “good pay” and “great benefits” (Glassdoor).
- Bonus, stock and equity-related rewards: Pfizer’s benefits overview includes performance bonuses and an employee stock purchase plan, and external review data includes positive sentiment around stock and equity. On an external review site, one employee said “stock options are great,” while another cited “commission and insurance” as strong parts of the compensation package (Comparably).
- Compensation, benefits and time off in employee reviews: Employees on external review sites frequently connect Pfizer’s compensation with benefits and paid time off. One process engineer described Pfizer as offering “Great benefits and PTO” and a “Great compensation package,” while another reviewer cited “competitive salary and benefits.” Another employee pointed to “salary and time off/vacation” as the best part of the compensation package. (Glassdoor; Indeed; Comparably)
- External signals:
- Pay and benefits ratings: Pfizer has a 4.1 rating for pay and benefits on one external review site. (Indeed)
- Perks, benefits and employee satisfaction: Pfizer has a B+ rating for perks and benefits, with 75% of employees saying they are satisfied with their benefits. (Comparably)
- Employee review themes: Employees on external review sites mention competitive salary, good pay, strong benefits, PTO, insurance, stock options and compensation packages. (Indeed; Glassdoor; Comparably)
Bottom line: Pfizer supports competitive pay and bonus plans through pay-for-performance practices, broad total rewards, performance bonuses, stock-related programs, financial benefits and compensation practices that employees describe as including strong pay, benefits, PTO and equity-related rewards.
Pfizer Insights
What We Do
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for pro-innovation/pro-patient policies.
Why Work With Us
We are the inventors, the problem solvers, the big thinkers — those who surmount any hurdle to deliver breakthrough medicines to the people who are counting on them the most.
Gallery
Pfizer Offices
Hybrid Workspace
Employees engage in a combination of remote and on-site work.









